PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2019.34.1.70201934170Retrospective Analysis of the Efficacy of Dapagliflozin in Patients with Type 2 Diabetes in a Primary Clinic in KoreaSang Hyun Park, Young Ju Choi, Eun-Jung Rhee, Kab Bum Huhhttps://synapse.koreamed.org/pdf/10.3803/EnM.2019.34.1.70, https://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2019.34.1.70, https://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2019.34.1.70
Diabetes Therapy10.1007/s13300-016-0193-8201674695-711Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective StudyJohn Wilding, Clifford Bailey, Una Rigney, Betina Blak, Wendy Beekman, Cathy Emmashttp://link.springer.com/content/pdf/10.1007/s13300-016-0193-8.pdf, http://link.springer.com/article/10.1007/s13300-016-0193-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s13300-016-0193-8.pdf
Primary Care Diabetes10.1016/j.pcd.2013.10.001201482127-131Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: A retrospective database analysisKarel Kostev, Franz-Werner Dippel, Wolfgang Rathmannhttps://api.elsevier.com/content/article/PII:S1751991813001174?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1751991813001174?httpAccept=text/plain
Diabetes, Obesity and Metabolism10.1111/dom.121872013162124-136Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 yearsJ. P. H. Wilding, V. Woo, K. Rohwedder, J. Sugg, S. Parikh, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.12187, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12187/fullpdf
Diabetes10.2337/db18-1180-p201867Supplement_1Efficacy and Safety of Long-Term Administration of Dapagliflozin for Japanese Patients with Type 2 Diabetes MellitusMASAHIRO YAMAZAKI, RYOSUKE SAKAI, TAKURO OKAMURA, MICHIAKI FUKUIhttps://diabetesjournals.org/diabetes/article/67/Supplement_1/1180-P/53963/Efficacy-and-Safety-of-Long-Term-Administration-of, https://diabetesjournals.org/diabetes/article/67/Supplement_1/1180-P/53963/Efficacy-and-Safety-of-Long-Term-Administration-of
Primary Care Diabetes10.1016/j.pcd.2013.03.003201373229-233Changes in time to insulin initiation in type 2 diabetes patients: A retrospective database analysis in Germany and UK (2005–2010)Karel Kostev, Wolfgang Rathmannhttps://api.elsevier.com/content/article/PII:S1751991813000417?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1751991813000417?httpAccept=text/plain
Diabetes, Obesity and Metabolism10.1111/dom.128532017194562-570Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trialEiichi Araki, Yukiko Onishi, Michiko Asano, Hyosung Kim, Toshitaka Yajimahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.12853, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12853/fullpdf
Diabetes Technology & Therapeutics10.1089/dia.2017.013420171911685-691Effect of Dapagliflozin on Glycemic Control, Weight, and Blood Pressure in Patients with Type 2 Diabetes Attending a Specialist Endocrinology Practice in Canada: A Retrospective Cohort AnalysisRuth E. Brown, Nikhil Gupta, Ronnie Aronsonhttp://www.liebertpub.com/doi/full-xml/10.1089/dia.2017.0134, http://www.liebertpub.com/doi/pdf/10.1089/dia.2017.0134
Primary Care Diabetes10.1016/j.pcd.2013.02.001201372167-171Influence of macro- and microvascular comorbidity on time to insulin initiation in type 2 diabetes patients: A retrospective database analysis in Germany, France, and UKKarel Kostev, Wolfgang Rathmannhttps://api.elsevier.com/content/article/PII:S1751991813000272?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1751991813000272?httpAccept=text/plain
Nephrology Dialysis Transplantation10.1093/ndt/gfaa142.p1050202035Supplement_3P1050THE EFFICACY AND RENAL SAFETY OF SWITCHING FROM DAPAGLIFLOZIN TO EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETESAI-YU YANG, Hung-Chun Chenhttp://academic.oup.com/ndt/article-pdf/35/Supplement_3/gfaa142.P1050/33360717/gfaa142.p1050.pdf, http://academic.oup.com/ndt/article-pdf/35/Supplement_3/gfaa142.P1050/33360717/gfaa142.p1050.pdf